The MALT1 locus and peanut avoidance in the risk for peanut allergy - 06/06/19
![](/templates/common/images/mail.png)
for the
Immune Tolerance Network LEAP Study Team
This research was performed as a project of the Immune Tolerance Network, an international clinical research consortium headquartered at the Benaroya Research Institute, and supported by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health under award no. UM1AI109565. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. |
|
Disclosure of potential conflict of interest: G. Lack reports holding stock and stock options in DBV Technologies. The rest of the authors declare that they have no relevant conflicts of interest. |
Vol 143 - N° 6
P. 2326-2329 - juin 2019 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?